Philip Murphy, MD, Beaumont Hospital, Dublin, Ireland, describes the treatment of younger patients with relapsed/refractory (R/R) multiple myeloma in Ireland. Treatment options for these patients include potentially a second transplant, and/or triplet combination therapy. Using the ESMO guidelines, the challenge for clinicians is to find a suitable combination therapy for patients. This interview was recorded virtually.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.